How does the USPTO handle applications related to ‘recombinant DNA’ inventions? The USPTO gives special attention to patent applications involving recombinant DNA inventions. According to MPEP 708: “Applications relating to recombinant DNA have been accelerated by the Office under the Director’s Initiative.” This means that: Recombinant DNA applications are prioritized for examination They are processed…

Read More